DV Biomed Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	113.96	213.98	226.25	456.83	557.62
Short-Term Investments	81.87	100.54	45.22	124	38.5
Trading Asset Securities	125.96	65.91	4.38	4.34	4.74
Cash & Short-Term Investments	321.79	380.42	275.85	585.17	600.86
Cash Growth	-15.41%	37.91%	-52.86%	-2.61%	11.62%
Accounts Receivable	29.53	55.05	80.19	239.56	292.18
Other Receivables	10.1	7	5.88	17	14.3
Receivables	39.63	62.06	86.07	256.55	306.49
Inventory	113.67	74.84	66.73	133.9	132.07
Prepaid Expenses	7.92	38.96	15.36	30.09	38.47
Other Current Assets	6.09	0.22	0.57	0.06	-
Total Current Assets	489.09	556.5	444.57	1,006	1,078
Property, Plant & Equipment	72.8	47.53	55.31	585.81	415.6
Long-Term Investments	36.8	30.04	-	182.43	178.23
Other Intangible Assets	2.38	4.12	0.9	3.43	5.32
Long-Term Accounts Receivable	-	67.51	-	-	-
Long-Term Deferred Tax Assets	66.33	65.57	66.22	77.03	64.33
Other Long-Term Assets	9.78	5.94	28.29	198.78	116.22
Total Assets	677.18	777.22	595.29	2,053	1,858
Accounts Payable	36.26	32.85	28	110.25	115.37
Accrued Expenses	47.12	41.27	68.78	81.54	83.78
Current Portion of Leases	15.56	32.11	3.75	80.66	62.32
Current Income Taxes Payable	-	4.7	-	41.52	43.05
Current Unearned Revenue	10.75	3.29	1.28	116.21	115.27
Other Current Liabilities	28.05	24.4	13.05	50.58	69.28
Total Current Liabilities	137.74	138.62	114.87	480.77	489.07
Long-Term Leases	29.95	99.63	-	385.86	161.77
Long-Term Deferred Tax Liabilities	0.04	0.94	0.12	6.92	-
Other Long-Term Liabilities	2.08	3.82	3.82	34.6	27.85
Total Liabilities	169.81	243.01	118.81	908.14	678.68
Common Stock	243.49	208.61	604.47	614.47	602.61
Additional Paid-In Capital	7.03	7.11	190.28	211.51	179.37
Retained Earnings	266.98	345.74	307.27	431.35	468.6
Treasury Stock	-	-14.55	-42.16	-100.69	-58.53
Comprehensive Income & Other	-10.13	-12.7	-13.09	-11.53	-13.16
Total Common Equity	507.37	534.21	1,047	1,145	1,179
Minority Interest	-	-	-570.29	-	-
Shareholders' Equity	507.37	534.21	476.48	1,145	1,179
Total Liabilities & Equity	677.18	777.22	595.29	2,053	1,858
Total Debt	45.51	131.74	3.75	466.52	224.09
Net Cash (Debt)	276.28	248.69	272.1	118.65	376.77
Net Cash Growth	11.09%	-8.60%	129.34%	-68.51%	30.65%
Net Cash Per Share	11.34	10.20	11.14	4.85	15.29
Filing Date Shares Outstanding	24.35	24.35	24.35	24.35	24.62
Total Common Shares Outstanding	24.35	24.35	24.35	24.35	24.62
Working Capital	351.35	417.88	329.7	525.01	588.81
Book Value Per Share	20.84	21.94	42.99	47.03	47.88
Tangible Book Value	504.99	530.08	1,046	1,142	1,174
Tangible Book Value Per Share	20.74	21.77	42.95	46.89	47.66
Buildings	-	-	55.62	81.98	80.66
Machinery	28.4	17.83	17.75	332.79	75.96
Construction In Progress	12.43	-	-	23	15.29
Leasehold Improvements	4.47	22.52	21.6	-	225.83

Source: S&P Global Market Intelligence. Standard template. Financial Sources.